Pluristem (PSTI) Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech

preview_player
Показать описание
Pluristem (PSTI) Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech
  1. CorporateProfile
  2. financial news
  3. business news
  4. stem cell research
  5. Pluristem
  6. PSTI
Рекомендации по теме
Pluristem (PSTI) Enters 0:02:45

Pluristem (PSTI) Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech

Pluristem CEO Zami 0:01:28

Pluristem CEO Zami Aberman - PSTI Entering Japan's Accelerated Pathway for Regenerative Medicin...

PSTI and CHA 0:01:54

PSTI and CHA Strategic Partnership Agreement; Conclude Mutual Investment of $10.4 Million

Pluristem Pursues Development 0:02:07

Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market

United Therapeutics Approved 0:02:36

United Therapeutics Approved to Commence Phase I Study of Pluristem's (PSTI) PLX-PAD Cells

PSTI Cell Manufacturing 0:01:36

PSTI Cell Manufacturing Facility Receives German Regulatory Approval of 3D Manufacturing Process

Israel's Ministry of 0:01:34

Israel's Ministry of Health Approves PSTI Commercial-Scale 3D Cell Manufacturing Process

PSTI (Pluristem Therapeutics) 0:05:20

PSTI (Pluristem Therapeutics) Stock Pick

UK's Minister for 0:02:06

UK's Minister for Univ.& Science Visits PSTI Regarding UK-Israel Coop on Regenerative Medic...

Pluristem Therapeutics 0:13:10

Pluristem Therapeutics

Pluristem Therapeutics 0:19:00

Pluristem Therapeutics

PSTI Critical Limb 0:01:48

PSTI Critical Limb Ischemia Phase III Trial Cleared in the US, UK, and Germany

PSTI and the 0:02:31

PSTI and the Alliance for Regenerative Medicine Advocate for Industry Advancement in D.C.

SNNLive Update with 0:08:34

SNNLive Update with Pluristem Therapeutics, Inc. (NASDAQ: PSTI) - February 2016

to be happy 0:03:08

to be happy in pluristem

Pluristem Therapeutics (PSTI) 0:03:59

Pluristem Therapeutics (PSTI) Bottom Play Stock

Pluristem and Hadassah 0:02:12

Pluristem and Hadassah Medical Center Collaborate to Study PLX-RAD Cells

Why Pluristem chose 0:01:23

Why Pluristem chose PAD as First Indication

Pluristem Strengthens Executive 0:01:56

Pluristem Strengthens Executive Team; Announces Senior Executive Appointments

Pluristem Therapeutics 0:14:34

Pluristem Therapeutics

Pluristem Therapeutics | 0:22:07

Pluristem Therapeutics | Benzinga Global Small Cap Conference December 2021

Pluristem Therapeutics - 0:09:45

Pluristem Therapeutics - Company Presentation

Pluristem Therapeutics CEO 0:03:11

Pluristem Therapeutics CEO talks about their latest Trail

Karine Kleinhaus, M.D, 0:14:34

Karine Kleinhaus, M.D, Pluristem's Divisional VP North America- Stem Cell Meeting on the Mesa 2...